Kitasato University – COVID-19 – June 2021
OSAKA, Japan, 11 June 2021 /PRNewswire/
Patent No. 5757975
Results revealed that the ClO2 aqueous solution
inactivated over 99.99% of SARS-CoV-2,
including the two variant strains.
Taiko Pharmaceutical’s patented long-lasting
ClO2 aqueous solution
(Patent No. 5757975, 3 years after production).
In 1962 the Kitasato University was
founded to mark the 50th anniversary of
the Kitasato Institute, Japan’s first
private medical research facility.
The National Institute of Infectious Diseases (NIID) is a research
institute attached to the Ministry of Health, Labour and Welfare.
Chlorine dioxide, is a highly reactive compound that takes the form of a yellow gas at ordinary temperature and pressure, is a free radical. As an oxidizing agent, it oxidatively modifies viral, bacterial, and fungal proteins and malodorous substances, resulting in the eradication of viruses and bacteria and elimination of odors.
The Green Pheasant